Date | Publication | Title |
---|---|---|
17 Apr. 2024 | Front Line Genomics | The $100 Genome: Where’s the Limit? |
12 Apr. 2024 | Reuters | EU approves Illumina's plan to divest cancer test maker Grail |
10 Apr. 2024 | San Diego Union Tribune | Illumina gets two new executives as the San Diego biotech revamps its C-suite |